SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet's GOOGL is trending as investors assess the potential impact of OpenAI's rumored browser launch on Google's search dominance, sparking debates about market share and future competition. The community is actively discussing whether this presents a buying opportunity or signals a genuine threat to Google's core business. Some are pointing to Google's AI advancements with Gemini and existing dominance as reasons to remain bullish.

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease. The company was founded by Rogerio Vivaldi Coelho and Goeffrey Robin Race on April 23, 2007 and is headquartered in Burlington, MA.

Minerva Neurosciences Inc

NERV is trending as the community discusses its volatile price action and potential for further gains, with some highlighting the small float and positive news as drivers. Others in the community caution against chasing the stock, suggesting it may be overbought or due for a pullback. The stock's behavior is being compared to other recent high-momentum plays in the biotech sector.

Alphabet Inc - Ordinary Shares - Class C

GOOG is trending as investors react to OpenAI's potential browser launch and its possible impact on Chrome, sparking debate about market share and Googles dominance. Community talking points include whether this is a buying opportunity and if Google's AI, Gemini, can compete effectively. Some traders also mention potential impacts from upcoming earnings and broader macroeconomic conditions.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is surging as the community rallies around the resurgence of OG memes and a shared bullish sentiment. Traders are highlighting the strong community engagement and encouraging others to embrace the "RAGE" lifestyle within the memecoin space. The focus remains on community growth and celebrating the iconic Rage Guy meme.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending amid discussions of its strong technicals and potential breakout, with community members eyeing key resistance levels and future price targets. Some users highlight Solana's growing ecosystem, including new memecoins and integration with various platforms, while others point to potential ETF catalysts. There is a strong community sentiment with the #WAGMI hashtag.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG is trending as the Bitcoin meme coin garners increased attention and volume, with the community highlighting its strong recovery and unique position on the Bitcoin blockchain. Discussions center on $DOG's fair launch, decentralized nature, and potential to outperform other meme coins, especially with growing support from the 'DOG Army'.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending as its community rallies around the token's six-month milestone, highlighting its evolution within the Solana ecosystem. Community members are emphasizing the token's strong, organic support and consistent presence. The broader conversation revolves around shared conviction and a long-term vision, with many expressing bullish sentiment.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

General Motors shares are trending upward following a Q3 earnings report that beat expectations despite a year-over-year decline due to tariffs and EV restructuring, with investors reacting positively to the company's raised full-year guidance. Community discussions focus on whether the stock can break through resistance levels and continue its upward momentum, while some analysts highlight GMs potential to offset tariff costs and capitalize on EV demand. The beat and guidance raise have prompted bullish sentiment, with some anticipating further gains.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets and Data Centers. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

Galaxy Digital ($GLXY) is trending due to anticipation surrounding an expected earnings beat, particularly related to its AI data center business and ERCOT approval progress. Community discussions revolve around institutional accumulation, potential analyst revisions, and the stock's strong correlation with the recovering crypto market. Some investors view GLXY as an early opportunity with significant growth potential in both the crypto and AI sectors, while others express concerns about day trading volatility.

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

GLD is trending amidst discussions of a potential rotation from gold to tech stocks and Bitcoin, with some traders noting the ETF's significant year-to-date gains while others anticipate a correction. Community members are actively debating gold's role as a safe haven asset, especially in light of U.S.-China trade talks and geopolitical tensions, with some expressing concerns about a possible bubble and overbought conditions.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Does Apogee Therapeutics Inc. (APGE) Have the Potential to Rally 72.52% as Wall Street Analysts Expect?

The consensus price target hints at a 72.5% upside potential for Apogee Therapeutics Inc. (APGE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

U.S. equities declined in Thursday afternoon trade as Wall Street took a breather following a record-setting rally. The S&amp;P 500 and the Nasdaq Composite indexes both climbed to record highs on Thursday, before paring the gains and declining to trade in the red at the time of writing.Meanwhile, silver prices&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/silver-spot-price-50-first-time-4-decades/ch67qedR3K8">continued to climb</a> on Thursday. Spot silver prices climbed to a new high of $51.38 per troy ounce, rising more than 5% before paring most of the gains.The&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY), which mirrors the S&amp;P 500 index, was down 0.41% at the time of writing, while the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust</a> (QQQ), which mirrors the Nasdaq 100 index, fell 0.45%. The&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust</a> (DIA), which tracks the Dow Jones Industrial Average, declined 0.52%.Here are the top stocks making the biggest moves in Thursday’s afternoon trade:<a href="https://stocktwits.com/symbol/DAL">Delta Air Lines Inc. (DAL)</a>Delta shares soared over 5% in Thursday’s afternoon trade after the airline’s third-quarter (Q3) results beat Wall Street expectations. Delta reported earnings per share (EPS) of $1.71 on revenue of $16.67 billion, beating analyst estimates of an EPS of $1.53 on revenue of $15.08 billion, according to Stocktwits data.<a href="https://stocktwits.com/symbol/DAL">DAL stock</a> is down 1% year-to-date.<a href="https://stocktwits.com/symbol/TLRY">Tilray Brands Inc. (TLRY)</a>Tilray Brands shares were up more than 23% in Thursday’s afternoon session after the company’s first-quarter (Q1)&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tilray-brands-stock-skyrockets-on-swing-to-profit-significant-debt-reduction/ch67ouWR3Kj">results</a> came in better than expectations. Tilray reported nil earnings per share (EPS) on revenue of $209.5 million, beating analyst estimates of a loss of $0.03 per share on revenue of $204.55 million, according to Stocktwits data.<a href="https://stocktwits.com/symbol/TLRY">TLRY stock</a> is up 59% year-to-date.<a href="https://stocktwits.com/symbol/PATH">UiPath Inc. (PATH)</a>UiPath shares climbed 15% in Thursday’s afternoon trade, building on the gains over the past few trading sessions following the announcement of collaboration with OpenAI on enterprise agentic automation. The stock surged over 5% on Wednesday and hit new 2025&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/ui-path-rises-extended-hours-after-hitting-new-2025-highs/ch67O1jR30f">highs</a> on AI momentum.<a href="https://stocktwits.com/symbol/PATH">PATH stock</a> is up 41% year-to-date.<a href="https://stocktwits.com/symbol/AKRO">Akero Therapeutics Inc. (AKRO)</a>Akero Therapeutics shares were up more than 16% on Thursday after the company announced that it had&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/akero-shares-rally-pre-market-after-announcing-acquisition-by-novo-nordisk/ch67VXUR3K7">entered</a> into a definitive agreement to be acquired by Novo Nordisk AS (NVO) for up to $5.2 billion in cash.<a href="https://stocktwits.com/symbol/AKRO">AKRO stock</a> is up 95% year-to-date.<a href="https://stocktwits.com/symbol/APGE">Apogee Therapeutics Inc. (APGE)</a>Apogee Therapeutics shares continued to gain on Thursday, rising more than 7% after surging 19% on Wednesday. The clinical-stage biotechnology company announced the pricing of a $300 million public offering at $41 per share.<a href="https://stocktwits.com/symbol/APGE">APGE stock</a> is up 12% year-to-date.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/silver-spot-price-50-first-time-4-decades/ch67qedR3K8">Silver Prices Hit $50 For First Time In Over 4 Decades</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A bull statue and a bear statue stand outside the Frankfurt Stock Exchange on April 7, 2025 in Frankfurt, Germany

Delta Air Lines, Tilray Brands, UiPath, Akero Therapeutics, Apogee Therapeutics: Stocks Making The Biggest Moves Today

Delta shares soared over 5% in Thursday’s afternoon trade after the airline’s third-quarter results beat Wall Street expectations.

Equity

Wall Street Analysts See a 152.41% Upside in Apogee Therapeutics Inc. (APGE): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 152.4% in Apogee Therapeutics Inc. (APGE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Wall Street Analysts See a 129.09% Upside in Apogee Therapeutics Inc. (APGE): Can the Stock Really Move This High?

Wall Street Analysts Think Apogee Therapeutics Inc. (APGE) Could Surge 132.72%: Read This Before Placing a Bet

XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details

10 mid-cap stocks jumped in last week, including QuantumScape, Lantheus Holdings, Sunrun, Kymera Therapeutics, Apogee Therapeutics, Joby Aviation, Crinetics Pharmaceuticals, Dyne Therapeutics, Summit...

Apogee (APGE) Stock Rallies 95.6% in a Month: Here's Why

Apogee Therapeutics Inc. APGE, a clinical-stage company, is focused on developing novel therapies for the treatment of atopic dermatitis (AD), asthma, chronic obstructive pulmonary disease...

Apogee Therapeutics Announces First Participants Dosed in Phase 1 Trial of APG808, its Novel Half-life Extended IL-4R  Antibody for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) and Other Inflammatory Diseases

Preclinical data with APG808 demonstrate the potential for improved dosing over other treatment options in development, including the potential for dosing every six- or eight- weeks compared to...

Apogee Therapeutics (NASDAQ:APGE) Stock Price Up 6%

Apogee Therapeutics, Inc. (NASDAQ:APGE  Get Free Report) rose 6% during trading on Friday . The company traded as high as $71.75 and last traded at $70.50. Approximately 222,641 shares traded...

Apogee Therapeutics, Inc. (NASDAQ:APGE) Given Average Rating of "Buy" by Analysts

Apogee Therapeutics, Inc. (NASDAQ:APGE  Get Free Report) has been given a consensus recommendation of Buy by the seven ratings firms that are presently covering the firm...

Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded in 2022 and is headquartered in Waltham, MA.

Apogee Therapeutics Inc.

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$55.60
Prev Close	$56.94
Open	$57.71
Dividend Yield	0.00%
50-Day Moving Average	$40.57
Beta	0.00
Avg. Volume	563,707.14
PE Ratio	-13.97

52-Week High	$63.50
52-Week Low	$26.20
Market Capitalization	$3.39B
EPS (Annual)	-$3.30
Price to Book	5.48
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

APGE
Apogee Therapeutics

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest APGE News

APGEApogee Therapeutics